Bellevue Group »

Accenture shares owned by Bellevue Group

Quarter-by-quarter ownership of Accenture (ACN) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Accenture

Tip: Access up to 7 years of quarterly data

All positions including Accenture held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Accenture by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $403k 1.5k 268.30

More positions owned by Bellevue Group

Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Ionis Pharmaceuticals (IONS)
Vertex Pharmaceuticals Incorporated (VRTX)
Neurocrine Biosciences (NBIX)
Avidity Biosciences Ord (RNA)
Intuitive Surgical Com New (ISRG)
Scholar Rock Hldg Corp (SRRK)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Amicus Therapeutics (FOLD)
Boston Scientific Corporation (BSX)
Miragen Therapeutics (VRDN)
Stryker Corporation (SYK)
Nuvalent Inc-a (NUVL)

View all positions for Bellevue Group

Top funds holding Accenture

Vanguard Group
BlackRock
State Street Corporation
Capital Research and Management Company - Division 3
Geode Capital Management
Sanders Capital
Massachusetts Financial Services
Wellington Management Company
Franklin Resources
Norges Bank Investment Management
Northern Trust
Jpmorgan Chase & Co
Wells Fargo & Company
Charles Schwab Investment Management
Ubs Global Asset Management Americas

View all funds holding Accenture